Skip to content

Clinical Study on The Treatment of Migraine with HUOXUESHUFENG grain

Clinical Study on The Treatment of Migraine with HUOXUESHUFENG grain

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001827
Enrollment
Unknown
Registered
2011-12-28
Start date
2011-12-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Experimental group:HUOXUESHUFENG grain
Control group:Placebo

Sponsors

The TCM Institute of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Eligible patients were fulfilling the wind Stasis Syndrome of syndrome differentiation classification of TCM specified by the 2002 Chinese medicine clinical research guidelines; 2. diagnosed as primary headache (mainly migraine without aura associated with migraine with typical aura-based ) according to the diagnostic criteria specified by the International Classification of Headache Disorders(IHS)(ICHDII) and the initial onset of age =3.6), affect learning or working; 7. no prophylactic treatment of migraine drugs such as beta-blockers, calcium channel blockers, antiepileptic drugs and so on in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. having Analgesics more than 10 times due to the migraine attacks every month; 2. special types of migraine, such as ophthalmoplegia migraine, hemiplegic migraine type; 3. cluster headache,tension-type headache and other secondary headache disorders; 4. pregnancy, lactation women; 5. combined with hepatic, renal, hematopoietic system and other serious primary disease; 6. having severe mental diseases; 7. Allergic Constitution.

Design outcomes

Primary

MeasureTime frame
the frequency of headache attack;

Secondary

MeasureTime frame
the severity of headache;the number of migraine days;the duration time of headache attack;headache accompanied symptom;the frequency of analgescics;the scores of TCM symptom;

Countries

China

Contacts

Public ContactQinJian Zeng
qinjzcn@fimmu.com+86 13602746909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026